In recent June AGM, the mgmt already explained its objectives of acquring Aoxin for better sales execution in North China mkt and the new projects for masks and covid-19 test kits via Acumen Diagnostics (approved under HSA Spore) In today fast moving mkt, e mgmt did e right thing by expanding its share in Acumen rather than rebuild or make it themselves, it will b too slowed by then. Biodics is an example, but theirs will take 9months slower than Q& M via Acumen which already started selling. Their orders r full and will announce soon. B patient. Impressed me most is Q& M has about 200 over employees including top mgmt, volunteered swap tests during Phase 1 CV-19, this demonstrates coy' s CSR n such intangible goodwill will go a long way like Medtecs who donated medical protective items to developing country Cambodia. Have respect for such leaders!
Yeap. You know which is crow and which is the real eagle now.
cycy818 ( Date: 16-Jul-2020 12:37) Posted:
|
Tell me how many listed dental clinic in SGX?
cycy818 ( Date: 16-Jul-2020 12:37) Posted:
|
Don' t get choked uncle 
  i just want to compare profits making and EBIDTA.  Now you don' t use crow anymore?
If Q& M can make masks. why can' t manufacture gloves in future ? 
 
  i just want to compare profits making and EBIDTA.  Now you don' t use crow anymore?If Q& M can make masks. why can' t manufacture gloves in future ? 
 
Shifu8888 ( Date: 16-Jul-2020 05:06) Posted:
|
Agree different league lah
Shifu8888 ( Date: 16-Jul-2020 05:06) Posted:
|
Bro, you use Ug as a comparison, I cannot stop laughing. This is a good morning joke. Sorry.
One makes glove
This joker plucks tooth and stuff (so many teeth to manage?) though try to join in the hype of making masks and also try hyping in with Covid test kit (kidding maybe)
Results for QM not as robust as before (I think with the lockdown) whereas UG results will fly though of course may have already been priced in.
One makes glove
This joker plucks tooth and stuff (so many teeth to manage?) though try to join in the hype of making masks and also try hyping in with Covid test kit (kidding maybe)
Results for QM not as robust as before (I think with the lockdown) whereas UG results will fly though of course may have already been priced in.
cycy818 ( Date: 16-Jul-2020 00:10) Posted:
|
I will never sell Q& M dental unless it hit 70c....  this local company have potential to rise like UG Healthcare at $1.54 (current price).
See UG Healthcare profits $2.03M and EBIDTA $5.5M as compared to Q& M profits $17.98M and EDIDTA $23.22M.
 
See UG Healthcare profits $2.03M and EBIDTA $5.5M as compared to Q& M profits $17.98M and EDIDTA $23.22M.
 
Short this everytime it tries to fake a fly. It?s a surety to make some coffee money.
coy $$$ fundamentals strong, gave good dividends lately. Will likey hit 0.6 soon or within 3 months
This one has not moved much yet.....
This stock seems to be the laggard behind the other medical stocks (MedTec, UG Healthcare) in spite of its recent diversification to acquire COVID-related revenue streams and despite it being a household name with a stable revenue base in SG - am keen to see where this goes in a few weeks.
with the 2nd and more waves coming, testing cannot stop
Look out for this stock carefully...
wenyen ( Date: 05-Jul-2020 18:53) Posted:
|
https://links.sgx.com/FileOpen/QnM_Acumen_Completion.ashx?App=Announcement& FileID=622639
COMPLETION OF THE ACQUISITION OF COVID-19 DIAGNOSTIC TEST KITS AND RELATED BUSINESS FROM ACUMEN RESEARCH LABORATORIES PTE. LTD.
COMPLETION OF THE ACQUISITION OF COVID-19 DIAGNOSTIC TEST KITS AND RELATED BUSINESS FROM ACUMEN RESEARCH LABORATORIES PTE. LTD.
Aoxin Q& M expects operating loss for FY20 from China' s prolonged closures
CATALIST-LISTED Aoxin Q& M Dental Group said on Friday that it expects to register an operating loss for FY20 on the back of its close-to-two-month closure of businesses in China.
 
It said that gestation losses from newly opened dental hospitals and clinics, and the possibility of a second wave of infections are likely to weigh on the group' s financial performance. Meanwhile, it will continue to monitor its revenue, cash flow and the evolving situation of Covid-19. 
 
In addition, the implementation of additional safety measures against the virus will result in additional costs, and is likely to impact the group&rsquo s financial results for FY20. It also said that it has no plans to open new hospitals or clinics for the year. 
 
Aoxin Q& M was responding to shareholders' questions through a regulatory filing ahead of its annual general meeting to be held the coming Monday.   . 
 
In response to queries regarding its increased employee benefit expenses, Q& M said that it was due to the six new hospitals and polyclinics opened in FY19. 
 
On whether there are plans to lay off staff if business does not pick up, Q& M said: " Management is actively assessing the operational performance of each hospital and polyclinic on a regular basis, and will fine tune the resources accordingly."
Very tempting to get some for their unpredictable annonucement😁
CHIONG ARH
Vaccine invented by QM. This crow will fly to $2.
Huat R.
Huat R.
Unless Q& M is again going to announce further collaborative work to fight the Covid virus, on top of its usual dental business.
ronleech ( Date: 12-Jun-2020 06:39) Posted:
|
will rhe possible 2nd wave o the world move this counter?